Von Eschenbach Andrew C. - Net Worth and Insider Trading
Von Eschenbach Andrew C. Net Worth
The estimated net worth of Von Eschenbach Andrew C. is at least $312,823 dollars as of 2024-09-19. Von Eschenbach Andrew C. is the Director of Bausch Health Companies Inc and owns about 38,647 shares of Bausch Health Companies Inc (BHC) stock worth over $310,142. Von Eschenbach Andrew C. is also the Director of Lineage Cell Therapeutics Inc and owns about 3,000 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $2,681. Details can be seen in Von Eschenbach Andrew C.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Von Eschenbach Andrew C. has not made any transactions after 2021-08-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Von Eschenbach Andrew C.
Von Eschenbach Andrew C. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Von Eschenbach Andrew C. owns 8 companies in total, including Bausch Health Companies Inc (BHC) , Asterias Biotherapeutics Inc (AST) , and Lineage Cell Therapeutics Inc (LCTX) among others .
Click here to see the complete history of Von Eschenbach Andrew C.’s form 4 insider trades.
Insider Ownership Summary of Von Eschenbach Andrew C.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BHC | Bausch Health Companies Inc | 2021-08-05 | director |
AST | Asterias Biotherapeutics Inc | 2014-04-01 | director |
LCTX | Lineage Cell Therapeutics Inc | 2013-08-12 | director |
2022-08-15 | director | ||
2021-11-09 | director | ||
2022-05-05 | director | ||
2023-08-10 | director | ||
2023-08-10 | director |
Von Eschenbach Andrew C. Latest Holdings Summary
Von Eschenbach Andrew C. currently owns a total of 2 stocks. Among these stocks, Von Eschenbach Andrew C. owns 38,647 shares of Bausch Health Companies Inc (BHC) as of August 5, 2021, with a value of $310,142 and a weighting of 99.14%. Von Eschenbach Andrew C. also owns 3,000 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 12, 2013, with a value of $2,681 and a weighting of 0.86%.
Latest Holdings of Von Eschenbach Andrew C.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BHC | Bausch Health Companies Inc | 2021-08-05 | 38,647 | 8.03 | 310,142 |
LCTX | Lineage Cell Therapeutics Inc | 2013-08-12 | 3,000 | 0.89 | 2,681 |
Holding Weightings of Von Eschenbach Andrew C.
Von Eschenbach Andrew C. Form 4 Trading Tracker
According to the SEC Form 4 filings, Von Eschenbach Andrew C. has made a total of 2 transactions in Bausch Health Companies Inc (BHC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Bausch Health Companies Inc is the acquisition of 1,400 shares on August 5, 2021, which cost Von Eschenbach Andrew C. around $36,316.
According to the SEC Form 4 filings, Von Eschenbach Andrew C. has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 3,000 shares on August 12, 2013, which cost Von Eschenbach Andrew C. around $11,070.
Insider Trading History of Von Eschenbach Andrew C.
- 1
Von Eschenbach Andrew C. Trading Performance
GuruFocus tracks the stock performance after each of Von Eschenbach Andrew C.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Von Eschenbach Andrew C. is 1.95%. GuruFocus also compares Von Eschenbach Andrew C.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Von Eschenbach Andrew C. within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Von Eschenbach Andrew C.'s insider trading performs compared to the benchmark.
Performance of Von Eschenbach Andrew C.
Von Eschenbach Andrew C. Ownership Network
Von Eschenbach Andrew C. Owned Company Details
What does Bausch Health Companies Inc do?
Who are the key executives at Bausch Health Companies Inc?
Von Eschenbach Andrew C. is the director of Bausch Health Companies Inc. Other key executives at Bausch Health Companies Inc include EVP & General Counsel Seana Carson , SVP & Controller & CAO John S Barresi , and EVP & Chief Financial Officer Tom George Vadaketh .
Bausch Health Companies Inc (BHC) Insider Trades Summary
Over the past 18 months, Von Eschenbach Andrew C. made no insider transaction in Bausch Health Companies Inc (BHC). Other recent insider transactions involving Bausch Health Companies Inc (BHC) include a net sale of 20,318 shares made by Seana Carson ,
In summary, during the past 3 months, insiders sold 13,370 shares of Bausch Health Companies Inc (BHC) in total and bought 0 shares, with a net sale of 13,370 shares. During the past 18 months, 20,318 shares of Bausch Health Companies Inc (BHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,318 shares.
Bausch Health Companies Inc (BHC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bausch Health Companies Inc Insider Transactions
Von Eschenbach Andrew C. Mailing Address
Above is the net worth, insider trading, and ownership report for Von Eschenbach Andrew C.. You might contact Von Eschenbach Andrew C. via mailing address: C/o Blco, 400 Somerset Corporate Blvd., Bridgewater Nj 08807.